Relmada Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Relmada Therapeutics (NASDAQ:RLMD) Earnings Estimates
2021 EPS Consensus Estimate: ($4.78)
Relmada Therapeutics (NASDAQ RLMD) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)